WO1995032181A1 - Fluoreszenzbestimmung der aktivität lipolytischer enzyme - Google Patents
Fluoreszenzbestimmung der aktivität lipolytischer enzyme Download PDFInfo
- Publication number
- WO1995032181A1 WO1995032181A1 PCT/EP1995/001919 EP9501919W WO9532181A1 WO 1995032181 A1 WO1995032181 A1 WO 1995032181A1 EP 9501919 W EP9501919 W EP 9501919W WO 9532181 A1 WO9532181 A1 WO 9532181A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycerol
- lipase
- lipases
- trinitrophenylaminododecanoyl
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/50—Pyrenes; Hydrogenated pyrenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
Definitions
- a method based on fluorimetry was developed to determine the activity of lipases of animal, plant and microbial origin (fungal and bacterial lipases) and lipases detectable in serum [lipoprotein lipase (LPL), hepatic lipase (HL), pancreatic lipase (PL)] .
- LPL lipoprotein lipase
- HL hepatic lipase
- PL pancreatic lipase
- fluorogenic triglyceride analogs have been synthesized in which an acyl or
- the fluorogenic lipid is solubilized with amphiphiles in the form of liposomes, vesicles, micelles or emulsions.
- the fluorogenic substrate can also be used as such in aqueous
- An essential part of the invention is the complexation of the fluorogenic
- Lipids with albumin in an aqueous medium and subsequent lyophilization which gives a solid "water-soluble" substrate for fluorimetric lipase analysis.
- the proposed method is suitable for numerous practical applications fertilize such as for lipase analysis in medical diagnostics, biotechnological enzyme production, the quality control of lipases used in organic chemistry, the detection of lipases or lipase inhibitors in food, and the enzyme screening of biological material.
- the stereoisomers of each of the fluorogenic lipids were prepared and used in various substrate forms (see above) for lipase determination. Different lipases showed very different stereospecificities on the fluorogenic substrates.
- the described method is therefore suitable for the discrimination of lipases in natural enzyme mixtures (eg serum) as well as for the screening (genetically modified) of modified enzymes.
- the radiometric methods are discontinuous methods in which the release of radioactively labeled fatty acids from a triglyceride is determined after separation from the unreacted starting compound. These methods are very complex due to the use of radioactivity and the poor reproducibility.
- ad2 The release of fatty acids from triglycerides is determined by means of alkali titration. However, large amounts of enzyme and substrate must be used for accurate measurements. This method is very prone to failure. In particular, this method is not well applicable to certain "substrate forms", for example if the substrate is solubilized with detergents or dissolved in organic solvents.
- ad 3a In this case, the formation of chromogenic carboxylic acids from their (glycerol) esters is determined photometrically (and fluorimetrically) (Boehringer Mannheim GmbH, European Patent 0207252B1). The sensitivity of these methods is not very high, but the fluorimetric methods are more sensitive and the substrates are more diverse.
- pyrenebutyric acid the fluorescence of which is suppressed by a quencher fatty acid adjacent to the molecule (e.g. bromohexanoic acid).
- a quencher fatty acid adjacent to the molecule e.g. bromohexanoic acid.
- Substrate cleavage leads to de-quenching and thus to an increase in fluorescence.
- fluorophores excimer technology
- fluorophore and quencher bromine acts at a few tenths of a nm distance
- the previously known substrates can at best be used in vesicles for determining the activity of enriched and pure enzymes.
- ERS ⁇ ZBL ⁇ T (RULE 26) Analyzes, however, lead to an association of pyrentriglyceride with apolipoproteins and albumin, which leads to the problem mentioned above.
- a substrate is therefore required which contains fluorophore and quencher in the same molecule and in which the quench effect does not or hardly depends on the conformation.
- Such quenching can be done by Resonance Energy Transfer (RET)
- fatty acid esters of fluorophores e.g. methylumbelliferone; Analytic Sciences February 1991, Vol. 7, 15-18
- fluoresce little intact and, after hydrolysis cleavage, fluoresce less Biochemica et Biophysica Acta, 1006 (1989) 84-88 ).
- substrate very high amounts of substrate are required here, which can lead to artifacts when analyzing native biological material.
- detergent is required for the solubilization of the lipophilic substrate. This often destroys the native biological milieu (e.g. solubilization of lipoproteins and denaturation of proteins in human serum) (Human Serum Lipoproteins, Fruchart & Shepherd, de Gruyter 1989).
- the present invention describes the chemical synthesis of new fluorogenic lipase substrates (lipid analogs).
- the optical measurement signal is independent of the conformation of the lipid substrate and thus also of the shape of the substrate.
- a new substrate form for the solubilization of the substrate is described, which can be used universally for the determination of lipase activities in biological and artificial environments.
- the substances used for a fluorometric measurement are compounds with the following structure:
- the compounds of the stated structure can be derived from sn-glycerol, where X, Y, Z can be 0.
- At least one of the radicals R 1 # 2 # 3 is an acyl or alkyl group which contains a fluorescent radical at the end and at least one further radical R 1 i2i3 is an acyl or alkyl radical which contains a chromophore bonded at the ⁇ end and which quenches the fluorescence of the fluorophore via resonance energy transfer (RET).
- RET resonance energy transfer
- At least one of the hydrocarbon chains which contain quenchers or fluorophore must preferably be bound to a primary alcohol function of the glycerol or propane structure via an acyl or thioester bond.
- a radical R, 2 3 can be an aliphatic hydrocarbon.
- X, Y or Z can also be S, NH or CH 2 .
- Fluorophore-substituted side chains R 1> 2 3 can be: I. preferably pyrene bonded to the ⁇ -end of an acyl or alkyl chain with a chain length of C 2 - C 20 with 0 to 6 double bonds. II.
- fluorophores perylene, anthryl, anthraniloyl, saliciloyl, tetracene, anthracene, phenanthrene, naphthalene, coumarone, coumarin, acridine, aminonaphtolsulfonic acid, phenyloxadiazole, diphenyloxazole, alloxenzophone, stilbene , Fluorene, fluorenone, p-quinone, methylumbelliferone, trinitrophenylamine, phenazine, phenylindole, quinoline, diphenylacetylene, benzothiophene, cyanothiocarbonyls, 1, 3,5,7-decatetraene, rhodamine, diphenylhexatriene, dansyl, 7-nitrobenz-2-oxa -1, 3-diazole (NBD), benzocarbazone, di
- Quencher-substituted side chains R 1 ⁇ 2 . 3 can be:
- pyrene as fluorophore, preferably trinitrophenylamine bonded to the ⁇ end of an acyl or alkyl chain with a chain length of C 2 -C 20 with 0 to 6 double bonds.
- the starting compound for the fluorogenic alkyldiacylglycerol is a 1-O-alkylglycerol, which by known methods (see Hermetter & Paltauf) in ether lipids; Biochemical and Biomedical Aspects (H. Mangold «St F. Paltauf, Editors). Academic Press, 1983, p. 389) is converted into a 1-O-alkyl-2-acyl-3-O-tritylglycerol (acylation protocol: F. Paltauf & A. Hermetter, Methods in Enzymology 197 (1 991) 134), the 2-acyl group the fluorophore or the Quencher can wear.
- the trityl group is replaced by a further acyl radical which is complementary to Position 2 carries a quencher or fluorophore.
- This method can also be used to make up the substituted 1,2-dialkyl-3-O-trityl, 1,2-acyl-2-O-alkyl-3-O-trityl and 1,2-diacyl-3-O-tritylglycerols to produce corresponding dialkylacyl and triacylglycerols, one side chain of the starting compound containing fluorophor or quencher and an acyl residue which contains quencher or fluorophore complementary to it being introduced via the trity exchange.
- 1,3-diacyl-2-acylamino-propanediols which are a fluorophore and a quencher, can be prepared by 1-acyl-2-acylamino-3-O-trityl-1,3-propanediols by trityl group exchange by this method -substituted acyl radical contain.
- the new substrates can be distributed by all conventional methods in an aqueous environment (Lipases, Borgström & Brockman (Editors), Elsevier, 1984), specifically in phospholipid vesicles, in detergent micelles and emulsions, or dissolved in organic solvents.
- a new solubilization (substrate) form is described here, the substrate being distributed in a defined molar ratio in the aqueous phase by complexing with a suitable protein, preferably bovine serum albumin (BSA).
- BSA bovine serum albumin
- an ethanolic solution of the lipid analog is injected into an aqueous buffer solution with a defined pH, which already contains BSA.
- the substrate form (lipid-protein complex) obtained in this way can be used both in biological and in artificial environments.
- the native composition of sensitive biological systems e.g. of human serum, not destroyed and the lipase activity of these samples can take place in the presence of their intact components (proteins, lipoproteins!).
- Lipid-binding proteins in particular the following substances, can generally be used as complexing protein: BSA, HSA (human
- ERS ⁇ ZBL ⁇ T serum albumin
- casein casein
- lactalbumin ovalbumin
- water-soluble apolipoproteins modified forms of the aforementioned proteins (methylated, carboxylated, acetylated and proteins modified by chemical or genetic methods).
- Both the fat-free and the commercially available proteins were examined.
- the complexes shown are associations of lipid and protein in a molar ratio of 1/1.
- the water-soluble lipid-protein complex can be freeze-dried using a lyophilizer and isolated as a solid powder. After redissolving in aqueous media, these preparations are suitable for measuring lipase activities.
- the lyophilization of the lipid-protein complex can be carried out in the absence or in the presence of buffers or mineral salts and of low or high molecular weight additives, preferably carbohydrates. Lyophilization is preferably carried out from a solution of 10 millimolar N- (2-hydroxyethyl) piperazine-N '- (2-ethanesulfonic acid) / NaOH (HEPES-
- the lyophilisate can preferably be redissolved in distilled water if the lyophilization was carried out from buffer salt solution, or in aqueous buffer solution which preferably contains HEPES-NaOH or phosphate or Tris-HCl, pH 7.4.
- the ethanol-water ratio is less than 1/100, v / v.
- This preparation can be used immediately for a lipase determination or, advantageously, after an equilibration phase of approximately 20 hours.
- the activity of the lipase can be determined continuously via the time-dependent increase in the fluorescence intensity (FIG. 1).
- the lipase (s) in the sample cleaves the lipid analog and leads by spatial separation of fluorophore and quencher to an increase in fluorescence linearly dependent on the extent of the hydrolysis.
- the low initial intensity of the fluorophore in the intact substrate is caused by the presence of fluorophore and quencher together on one molecule. This base value is therefore an important indicator for the quenching of the fluorophore in the substrate and thus for the quality and
- the lipase determination can also be carried out as an end point method, with a simple reading of the increase in fluorescence intensity taking place after a defined incubation time.
- the fluorescence measurement itself can be carried out in a continuous or discontinuous form with a fluorescence spectrometer, fluorescence microscope or plate reader.
- the lipase-induced cleavage of the fluorogenic substrate can be calculated quantitatively from the increase in the fluorescence intensity with the aid of a calibration curve (FIG. 2), which was created using unquenched pyrene-substituted triglycerides.
- the substrate conversion which is obtained from the time-dependent increase in fluorescence, corresponds to the increase in the fluorescent cleavage products which, after thin-layer chromatographic separation on silica gel (mobile phase: petroleum ether / chloroform / glacial acetic acid 96/4/1) and elution with chloroform / methanol 2/1 fluorimetric were determined.
- Colipase hepatic lipase; as well as lipases from Pseudomonas species, Chromobacterium viscosum, Candida rugosa, Rhizopus arrhizus, Geotrich ⁇ m candidum.
- the present invention can be put into practical use in the following important areas of lipase analysis.
- SPARE BLADE (RULE 26) sen, which lead to organ damage, whereby enzymes are released into the serum, which either do not occur at all or only in a very low concentration (eg in the case of carcinomas or inflammatory processes of the liver and the pancreas, or damage to these organs in the case of alcoholism ).
- RULE 26 SPARE BLADE
- Stereoisomers of the substances of the formulas I and II can be used for the screening of different stereoselectivities of natural and chemically and genetically modified lipases.
- the sn-1 acyl isomer of compound II of lipoprotein lipase is converted about 25 times faster than the sn-3 acyl isomer.
- Other lipases, which can be detectable in the serum, such as, for example, pancreatic lipase, show lower stereophonic preferences. The proportion of lipoprotein lipase in the total lipase activity of the serum can therefore be determined from the degree of the stereo preference measured.
- a kit for determining the activity of lipases in particular lipoprotein, hepatic and pancreatic lipases, is also provided, comprising a lipase, in particular a lipoprotein, hepatic and / or pancreatic lipase, as a positive control and one or more compounds according to one of claims 1 to 1 5 and usual auxiliary substances.
- 1 -Q-Hexadecyl-sn-glycerol is tritylated with trityl chloride at the sn-3 position (see Hermetter & Paltauf in Etherlipids; Biochemical and Biomedical Aspects (H. Mangold & F. Paltauf, Editors), Academic Press, 1983, p. 389) and the resulting alkyltritylglycerol with pyrendecanoic acid on the still free sn-2 OH-
- rac.1 -oloyl-glycerol rac.1 -oloyl-3-0-trityl-glycerol is produced from rac.1- which contains pyrendodecanoic anhydride in rac.1-
- Oleoyl-2-pyrendodecanoyl-3-0-tritylglycerol is converted.
- the conversion of the diacyltritylglycerol (200 mg, 209.8 // mol) with trinitrophenylaminododecanoic anhydride (525.5 mg, 629.4 // mol) in the presence of boron trifluoride etherate (50%) gives rac.1-oleoyl -2-pyrendodecanoyl-3- (2 ', 4', 6'-trinitrophenylamino-dodecanoyD-glycero! (122, 1 mg, 109, 1 / mol, 52% yield).
- the acylalkylglycerol (146 mg, 188 // mol) was then trinitrophenylaminododecanoic acid (100 mg, 230 // mol) in the presence of 52 mg dimethylaminopyridine (423 // mol) and 42 mg dicyclohexylcarbodimide (200 / mol) in 5 ml Acylated chloroform.
- the rac.1 -pyrendecanoyl-2-0-hexadecyl-3- (2 ', 4', 6'-trinitrophenylaminododecanoyl) glycerol formed was turned on
- the synthesis starts from rac.1 -Tetradecanoylamino-3-0-tritylpropanediol, which was prepared according to the literature procedure (R. Dijkman, N. Dekker, and GH Haas, Biochim.Biophys.Acta 1043 (1 990) 67-74).
- acyltritylpropanediol was esterified with pyrendecanoic acid to rac.1-tetradecanoylamino-2-pyrendecanoyl-3-O-tritylpropanediol (the same method was used for the acylation of alkyltritylglycerols, see Hermetter & Paltauf in ether lipids;
- the lipase activity of the sample in pmol converted substrate / test volume / time unit (here 2.1 pmol / ml / min) is determined from the slope of the increase in fluorescence (FIG. 1) and via a calibration line
- Fig. 2 determined which was obtained for known concentrations of hexadecylpyrenecanoyltritylglycerol (HPTG) in aqueous albumin solution.
- HPTG hexadecylpyrenecanoyltritylglycerol
- ERS ⁇ ZBLA ⁇ T (RULE 26) set amount of enzyme (in ⁇ g) (Fig. 3).
- Example 2 the activity of 1 ug Lipoprotein ⁇ lipase (from cow's milk) to an albumin-substrate complex of BSA and 1- (2, 4, 6, -Trinitrophenvlaminododecanovl) -2-pyrendecanovl-3- 0-hexadecyl-sn-glycerol (Example 2) determined to be 52.3 pmol / ml / min.
- Example 12 As described in Example 12, the activity of 1 ⁇ g lipoprotein lipase (from cow's milk) on an albumin-triglyceride complex of BSA and 1-O-dodecyl-2-pyrendecanoyl-3- (2 ', 4', 6 ' -trinitrophenylaminododecanoyl) -sn_-glycerol (Example 3) determined to 6 pmol / ml / min.
- the lipoprotein lipase activity was determined according to the example 1 2 Regulation determined.
- BSA bovine serum albumin
- HSA human serum albumin
- lipases showed clear activities: swine pancreatic lipase (PL) (from Boehringer Mannheim GmbH), lipoprotein lipase (LPL) from human serum and cow's milk, as well as human serum and breast milk; microbial lipases from: Chromobacterium viscosum, Candida rugosa, Rhizopus arrhizus, Pseudomonas species (from Nagase Biochemicals, Ltd., Japan), Geotrichum candid ⁇ m.
- PL pancreatic lipase
- LPL lipoprotein lipase
- microbial lipases from: Chromobacterium viscosum, Candida rugosa, Rhizopus arrhizus, Pseudomonas species (from Nagase Biochemicals, Ltd., Japan), Geotrichum candid ⁇ m.
- Lipoprotein lipase used LPL from cow's milk.
- Serum lipase activity before heparinization low to no activity
- Serum lipase activity before heparinization 60 pmol / ml / min
- Example 12 The complex of fluorogenic substrate and bovine serum albumin obtained in Example 12 in an aqueous medium is frozen at -75 ° C. and then lyophilized.
- a lyophilisate was prepared from albumin and fluorogenic substrate, a solution of 25 mg glycogen in 3 ml of 10 mM HEPES, pH 7.4 (pH adjustment with NaOH) being used as the aqueous medium.
- a lyophilizate was prepared from albumin and fluorogenic substrate, a solution of 25 mg of sucrose in 3 ml of 10 mM Na phosphate buffer, pH 7.4, being used as the aqueous medium.
- a lyophilizate was prepared from albumin and fluorogenic substrate, a solution of
- Lyophilisate activity (pmol / ml / min) from Tris / HCl 7 from HEPES + glycogen 1 2 from phosphate buffer + sucrose 10 from PBS + starch 13
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95920070A EP0710225A1 (de) | 1994-05-19 | 1995-05-19 | Fluoreszenzbestimmung der aktivität lipolytischer enzyme |
JP7530054A JPH09501185A (ja) | 1994-05-19 | 1995-05-19 | 脂質溶解性酵素の活性の蛍光測定 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0102994A ATA102994A (de) | 1994-05-19 | 1994-05-19 | Fluoreszenzbestimmung der aktivität lipolytischer enzyme |
ATA1029/94 | 1994-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995032181A1 true WO1995032181A1 (de) | 1995-11-30 |
Family
ID=3505141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1995/001919 WO1995032181A1 (de) | 1994-05-19 | 1995-05-19 | Fluoreszenzbestimmung der aktivität lipolytischer enzyme |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0710225A1 (de) |
JP (1) | JPH09501185A (de) |
AT (1) | ATA102994A (de) |
WO (1) | WO1995032181A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042497A2 (en) * | 2000-11-27 | 2002-05-30 | Memorial Sloan-Kettering Cancer Center | Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
WO2017040983A1 (en) * | 2015-09-03 | 2017-03-09 | The University Of Chicago | Systems and methods for characterization of hypertriglyceridemia |
US9957546B2 (en) | 2008-03-04 | 2018-05-01 | The Trustees Of The University Of Pennsylvania | Vivo detection of phospholipase activation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0037583A1 (de) * | 1980-04-09 | 1981-10-14 | KSV-Chemicals Oy | Verfahren zur fluorimetrischen Bestimmung der Aktivität von fettspaltenden Enzymen und Mittel zur Durchführung dieses Verfahrens |
-
1994
- 1994-05-19 AT AT0102994A patent/ATA102994A/de not_active IP Right Cessation
-
1995
- 1995-05-19 WO PCT/EP1995/001919 patent/WO1995032181A1/de not_active Application Discontinuation
- 1995-05-19 JP JP7530054A patent/JPH09501185A/ja active Pending
- 1995-05-19 EP EP95920070A patent/EP0710225A1/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0037583A1 (de) * | 1980-04-09 | 1981-10-14 | KSV-Chemicals Oy | Verfahren zur fluorimetrischen Bestimmung der Aktivität von fettspaltenden Enzymen und Mittel zur Durchführung dieses Verfahrens |
Non-Patent Citations (4)
Title |
---|
A. NEGRE ET AL.: "Hydrolysis of fluorescent pyrenetriacylglycerols by lipase from human stomach and gastric juice", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 963, 1988, pages 340 - 348 * |
E. GRUND ET AL.: "Conformational effects on the fluorescence of pyrene-labeled alkyldiacyl glycerols in different model membranes", JOURNAL OF FLUORESCENCE, vol. 4, no. 4, 1994, pages 365 - 366 * |
T. THUREN ET AL.: "Phospholipase A2 assay using an intramolecularly quenched pyrene-labeled phospholipid analog as a substrate", ANALYTICAL BIOCHEMISTRY, vol. 170, no. 1, 1988, pages 248 - 255 * |
T. THUREN, P. J. KINNUNEN: "A continuous fluorometric assay for phospholipase C from Clostridium perfringens", CHEMISTRY AND PHYSICS OF LIPIDS, vol. 59, 1991, pages 69 - 74 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042497A2 (en) * | 2000-11-27 | 2002-05-30 | Memorial Sloan-Kettering Cancer Center | Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
WO2002042497A3 (en) * | 2000-11-27 | 2003-02-06 | Sloan Kettering Inst Cancer | Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
US9957546B2 (en) | 2008-03-04 | 2018-05-01 | The Trustees Of The University Of Pennsylvania | Vivo detection of phospholipase activation |
US11034994B2 (en) | 2008-03-04 | 2021-06-15 | The Trustees Of The University Of Pennsylvania | In vivo detection of phospholipase activation |
WO2017040983A1 (en) * | 2015-09-03 | 2017-03-09 | The University Of Chicago | Systems and methods for characterization of hypertriglyceridemia |
Also Published As
Publication number | Publication date |
---|---|
EP0710225A1 (de) | 1996-05-08 |
JPH09501185A (ja) | 1997-02-04 |
ATA102994A (de) | 1995-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4668623A (en) | Method of fluorometrically measuring the activity of fat-degrading enzymes | |
EP0207252B1 (de) | Aromatische Hydroxy- oder Thiol-Derivate von Carbonsäureestern als Lipasesubstrate | |
EP0331167B1 (de) | Substrate für Phospholipasen | |
DE69029269T2 (de) | Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze | |
DE69828035T2 (de) | Nachweis von mikrobiellen metaboliten | |
US5089392A (en) | Fluorogenic substrates for measurement of lysosomal enzyme activities within intact cells | |
DE60001979T2 (de) | Neue Substrate zur Detektion von mikrobiellen Metaboliten | |
EP0399409A2 (de) | Fluorogene Verbindungen und ihre Verwendung | |
DE69225794T2 (de) | Test zur bestimmung von estersubstraten | |
DE68921385T2 (de) | Signalerhöhung im Enzym-Nachweis. | |
EP0423632A1 (de) | Hydrolase-Substrate | |
US5308766A (en) | Hydrolytic enzyme inhibitors/inactivators and methods for using same | |
WO1995032181A1 (de) | Fluoreszenzbestimmung der aktivität lipolytischer enzyme | |
EP0247373B1 (de) | 7-(Phenylacetamido)-4-alkylcumarine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Verfahren zur fluorometrischen Bestimmung der Aktivität von Hydrolasen, insbesondere von Penicillin-G-Acylase | |
DE19919634C2 (de) | Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer fluoreszenz-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen | |
Arora et al. | Ceramide-like synthetic amides that inhibit cerebroside galactosidase | |
AT412345B (de) | Optisch detektierbare organophosphonate | |
DE602004008900T2 (de) | Fluoreszenzsubstrate zum nachweis von organophosphatase-enzymaktivität | |
Manna et al. | Real-time cell assays of phospholipase A2s using fluorogenic phospholipids | |
DE60036584T2 (de) | Ein permanentes fluoreszenz-testverfahren | |
Hermetter et al. | Fluorescence screening for lipolytic enzymes | |
DD244826A5 (de) | Verfahren zur optischen Bestimmung der Lipase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995920070 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1995920070 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 586783 Date of ref document: 19970306 Kind code of ref document: A Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995920070 Country of ref document: EP |